Myeloma MRD by deep sequencing from circulating tumor DNA does not correlate with results obtained in the bone marrow.
Fiche publication
Date publication
novembre 2018
Journal
Blood advances
Auteurs
Membres identifiés du Cancéropôle Est :
Dr CHRETIEN Marie-Lorraine
Tous les auteurs :
Mazzotti C, Buisson L, Maheo S, Perrot A, Chretien ML, Leleu X, Hulin C, Manier S, Hébraud B, Roussel M, Do Souto L, Attal M, Avet-Loiseau H, Corre J
Lien Pubmed
Mots clés
Biomarkers, Tumor, genetics, Bone Marrow, metabolism, Circulating Tumor DNA, chemistry, High-Throughput Nucleotide Sequencing, Humans, Multiple Myeloma, diagnosis, Neoplasm, Residual, Plasma Cells, metabolism, Sequence Analysis, DNA, V(D)J Recombination, genetics
Référence
Blood Adv. 2018 11 13;2(21):2811-2813